Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2023 | 11-2022 | 08-2022 | 05-2022 | 02-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 7 | 1 | 1 | 1 |
| Accounts receivable | -14 | 1 | 32 | -9 | -6 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 509 | -189 |
| Other Working Capital | -140 | 226 | -783 | 501 | -189 |
| Other Operating Activity | -316 | -416 | -349 | -1,005 | -52 |
| Operating Cash Flow | $-470 | $-182 | $-1,099 | $-2 | $-435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 0 | -2 |
| Other Investing Activity | -42 | -38 | -65 | -88 | -81 |
| Investing Cash Flow | $-42 | $-38 | $-65 | $-88 | $-84 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -9 | -5 | -2 | -2 |
| Common Stock Issued | 1,196 | 0 | 1,157 | 0 | 0 |
| Other Financing Activity | -63 | -4 | 34 | 10 | 31 |
| Financing Cash Flow | $1,133 | $-13 | $1,187 | $8 | $29 |
| Beginning Cash Position | 32 | 265 | 242 | 323 | 813 |
| End Cash Position | 652 | 32 | 265 | 242 | 323 |
| Net Cash Flow | $620 | $-233 | $23 | $-81 | $-490 |
| Free Cash Flow | |||||
| Operating Cash Flow | -470 | -182 | -1,099 | -2 | -435 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -470 | -182 | -1,099 | -2 | -438 |